Germany – Pharmaceutical products – Drug discount agreements from January 1st, 2027 on various active ingredients as part of an open house procedure
TenderZenith matches this tender's eligibility criteria against your company profile to calculate a deterministic qualification score and identify potential disqualifiers.
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Description & Project Overview
The subject of this publication is the conclusion of contracts in accordance with Section 130a Paragraph 8 SGB V for various active ingredients within the framework of a so-called open house procedure: All suitable and interested pharmaceutical companies or communities of pharmaceutical companies are offered the conclusion of discount contracts in accordance with Section 130a Paragraph 8 SGB V by specifying uniform contract conditions and a uniform access procedure. The earliest contract start date is January 1st, 2027. Based on this, the contract term is usually a maximum of 24 months.